Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
US6982248B2 · kind B2 · utility
54Cited by
6References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2001 |
| Grant date | Jan 3, 2006 |
| Priority date | — |
| Expiry date | Jun 9, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Individuals in need of treatment of ischemia-related reperfusion are treated, preferably intravenously, with a composition which includes a compound which binds to a receptor for the glucagon-like peptide-1. The invention relates to both the method and compositions for such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.